Results 101 to 110 of about 1,796 (193)

Status Epilepticus and Beyond: A Clinical Review of Status Epilepticus and an Update on Current Management Strategies in Super-refractory Status Epilepticus [PDF]

open access: yes, 2017
Status epilepticus and refractory status epilepticus represent some of the most complex conditions encountered in the neurological intensive care unit. Challenges in management are common as treatment options become limited and prolonged hospital courses
Roy Poblete, Gene Sung
core   +1 more source

Ketamine Dosing Across Clinical Indications: A Narrative Review Organized by Proposed NMDA‐Related Mechanisms

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 6, June 2026.
Abstract Ketamine is a non‐competitive antagonist at the N‐methyl‐D‐aspartate (NMDA) glutamate receptor. It was approved by the US Food and Drug Administration for anesthesia in 1970. The only other related US regulatory approval since then has been for esketamine nasal spray for depression in 2019. Over this time ketamine has been repurposed by mainly
Paul Glue, Ben Beaglehole
wiley   +1 more source

Vagus Nerve Stimulation (VNS) in Super Refractory New Onset Refractory Status Epilepticus (NORSE)

open access: yes, 2019
The treatment protocol of status epilepticus has many associated toxicities so there is interest in alternate nonmedicinal therapies for managing New Onset Refractory Status Epilepticus (NORSE) patients.
Mohankumar Kurukumbi   +3 more
core   +1 more source

Rapid recovery after intrathecal dexamethasone in FIRES

open access: yes
Epileptic Disorders, Volume 28, Issue 3, Page 884-887, June 2026.
João Filipe Nico   +8 more
wiley   +1 more source

Refractory and super-refractory status epilepticus in adults: a 9-year cohort study.

open access: yes, 2017
While status epilepticus (SE) persisting after two antiseizure agents is called refractory (RSE), super-refractory status epilepticus (SRSE) defines SE continuing after general anaesthesia.
Marchi, N.A.   +4 more
core   +1 more source

First‐in‐man allopregnanolone use in super‐refractory status epilepticus

open access: yes, 2017
Super‐refractory status epilepticus (SRSE) is associated with high morbidity and mortality. Treatment of SRSE is complicated by progressive cortical hyperexcitability believed to result in part from synaptic GABA receptor internalization and ...
Cole, Andrew   +7 more
core   +1 more source

NORSE and Super-Refractory Status Epilepticus: a Single-Center Retrospective Chart Review

open access: yes, 2018
Rationale: New-Onset Refractory Status Epilepticus (NORSE) is a rare life-threatening condition in previously healthy patients who develop new-onset medically-refractory status epilepticus of unclear etiology.1NORSE commonly leads to super-refractory ...
Rezayee, Manaz
core   +1 more source

Treatment of convulsive status epilepticus in Brazil: a review

open access: yesArquivos de Neuro-Psiquiatria
Status epilepticus (SE) is the most severe presentation of epilepsy. Currently, SE is defined according to 2 sequential time frames: time 1, after which it is unlikely that the seizure will resolve spontaneously, therefore requiring the initiation of ...
Luis Otavio Caboclo
doaj   +1 more source

Vagus nerve stimulation in refractory and super-refractory status epilepticus - A systematic review

open access: yes, 2019
RATIONALE: Refractory status epilepticus (RSE) is the persistence of status epilepticus despite second-line treatment. Super-refractory SE (SRSE) is characterized by ongoing status despite 48 h of anaesthetic treatment.
Dibué-Adjei, Maxine   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy